Dementias Withdrawn Phase 2 Trials for Encenicline (DB11726)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02246075Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving MemantineTreatment